Minerva Surgical Inc Quick Ratio (UTRS) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Minerva Surgical Inc   (NASDAQ: UTRS)

Minerva Surgical Inc 's Quick Ratio

UTRS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0.54 below Minerva Surgical Inc average.

Within Medical Equipment & Supplies industry 153 other companies have achieved higher Quick Ratio than Minerva Surgical Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 1887 to 2605.

Explain Quick Ratio?
How much Cash & cash equivalents UTRS´s has?
What are UTRS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UTRS Quick Ratio (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q3		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3
Y / Y Current Liabilities Change -8.03 % -24.41 % -34.89 % -28.53 % -66.15 %
Y / Y Cash & cash equivalent Change -26.38 % -29.81 % -9.49 % -82.9 % 146.61 %
Quick Ratio MRQ 0.54 0.9 1.51 0.5 0.67
UTRS's Total Ranking # 2605 # 1887 # 209 # 2515 # 2370
Seq. Current Liabilities Change 18 % 4.71 % 19.9 % -37.93 % -3.01 %
Seq. Cash & cash equivalent Change -29.2 % -37.78 % 263.8 % -54.06 % -32.49 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 154
Healthcare Sector # 865
Overall Market # 2605


Quick Ratio Statistics
High Average Low
1.78 0.89 0.09
(Dec 31 2021)   (Sep 30 2021)




Financial Statements
Minerva Surgical Inc 's Current Liabilities $ 21 Millions Visit UTRS's Balance sheet
Minerva Surgical Inc 's Cash & cash equivalent $ 11 Millions Visit UTRS's Balance sheet
Source of UTRS's Sales Visit UTRS's Sales by Geography


Cumulative Minerva Surgical Inc 's Quick Ratio

UTRS's Quick Ratio for the trailling 12 Months

UTRS Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -24.21 % -47.57 % -53.89 % -39.02 % -24.5 %
Y / Y Cash & cash equivalent TTM Growth -44.31 % -35.05 % -34.64 % -8.11 % 178.06 %
Quick Ratio TTM 0.86 0.89 0.91 0.85 1.17
Total Ranking TTM # 3938 # 3908 # 765 # 2328 # 1690
Seq. Current Liabilities TTM Growth -2.56 % -7.41 % -10.51 % -6.13 % -32.59 %
Seq. Cash & cash equivalent TTM Growth -6.33 % -9.57 % -3.66 % -31.76 % 9.26 %

Quick ratio ranking by company, industry and sector >> Back to UTRS Financial Strength Comparisons >> Go to Compare UTRS Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in UTRS's Current Liabilities to $20.63 millions, cumulative Quick Ratio to 0.86 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 222 other companies have achieved higher Quick Ratio than Minerva Surgical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3908 to 3938.

Explain Quick Ratio?
How much Cash & cash equivalents UTRS´s has?
What are UTRS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 223
Healthcare Sector # 1072
Within the Market # 3938


trailing twelve months Quick Ratio Statistics
High Average Low
1.1 0.83 0.57
(Sep 30 2022)   (Mar 31 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Harvard Apparatus Regenerative Technology Inc   1.42 $ 1.501  Millions$ 1.055  Millions
Milestone Scientific Inc   1.41 $ 4.621  Millions$ 3.279  Millions
Motus Gi Holdings Inc   1.35 $ 5.724  Millions$ 4.247  Millions
Haemonetics Corporation  1.33 $ 351.005  Millions$ 264.215  Millions
Cadre Holdings inc   1.32 $ 69.412  Millions$ 52.739  Millions
Axogen inc   1.28 $ 32.588  Millions$ 25.550  Millions
Electromed Inc   1.22 $ 7.024  Millions$ 5.776  Millions
Retractable Technologies Inc  1.22 $ 11.258  Millions$ 9.262  Millions
Sharecare Inc   1.16 $ 128.008  Millions$ 110.615  Millions
Strata Skin Sciences Inc  1.13 $ 7.131  Millions$ 6.304  Millions
Envista Holdings Corporation  1.10 $ 824.200  Millions$ 746.800  Millions
Jin Medical International Ltd  1.09 $ 9.769  Millions$ 8.924  Millions
Tenon Medical Inc   1.09 $ 3.371  Millions$ 3.085  Millions
Brainsway Ltd   1.08 $ 10.520  Millions$ 9.761  Millions
Plus Therapeutics Inc   1.06 $ 11.006  Millions$ 10.421  Millions
Prosomnus Inc   1.04 $ 12.022  Millions$ 11.578  Millions
Establishment Labs Holdings Inc   1.04 $ 52.190  Millions$ 50.302  Millions
Angiodynamics Inc   1.00 $ 57.586  Millions$ 57.452  Millions
Embecta Corp   0.99 $ 326.500  Millions$ 329.300  Millions
Cerus Corporation  0.99 $ 79.006  Millions$ 80.122  Millions
Innovage Holding Corp   0.97 $ 135.231  Millions$ 138.813  Millions
Artivion Inc   0.97 $ 53.481  Millions$ 54.959  Millions
Vapotherm Inc   0.96 $ 14.418  Millions$ 14.947  Millions
Biolife Solutions Inc   0.96 $ 41.029  Millions$ 42.622  Millions
Baxter International Inc   0.92 $ 5,716.000  Millions$ 6,209.000  Millions
Allurion Technologies Inc   0.92 $ 79.866  Millions$ 87.228  Millions
Envoy Medical Inc   0.90 $ 11.440  Millions$ 12.690  Millions
Neuropace Inc   0.90 $ 10.117  Millions$ 11.243  Millions
Vaso Corporation  0.89 $ 26.893  Millions$ 30.298  Millions
Nuo Therapeutics Inc   0.85 $ 0.583  Millions$ 0.685  Millions

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.